Bloomberg: The Way Ahead

10.01.2020

Emergent BioSolutions, a Wells Fargo Corporate & Investment Banking customer since 2011, helps governments respond to health emergencies before they happen. Eight years ago, they were planning for a crisis like Covid-19. America will need hundreds of millions of doses of a vaccine. Emergent is manufacturing them now, before they've been approved for use, so they'll be ready if they measure up.

Watch the full story here.

Emergent CDMO

COVID-19 In The News

09.01.2022

EXECUTIVE INTERVIEW – Emergent CDMO: A Molecule-to-Market Partner for Complex Biologics

For nearly 25 years, Emergent has developed, manufactured, and delivered their own innovative vaccines and biotherapeutic...

04.14.2022

Molecule to Market: Inside the Outsourcing Space

Emergent recently had the pleasure of participating in the Molecule to Market Podcast hosted by Ramen Sehgal from from ra...

04.26.2023

Case Study Corner: LNP Formulation

Your biggest challenges inspire us. That's why Emergent supports innovative drug makers that make the seemingly impossible...